Skip to main content
Erschienen in: Abdominal Radiology 8/2017

14.03.2017

Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis

verfasst von: Azadeh Elmi, Janet Murphy, Sandeep Hedgire, Shaunagh McDermott, Seyed-Mahdi Abtahi, Elkan Halpern, Carlos Fernandez-del Castillo, Mukesh Harisinghani

Erschienen in: Abdominal Radiology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the survival outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) who had regular imaging surveillance with those who had clinical follow-up after Whipple.

Method

We identified 229 patients, who underwent Whipple for resection of PDAC from 2005 to 2011, and had regular postoperative clinical follow-up at our hospital. Patients were retrospectively selected for two follow-up groups: imaging surveillance (IS) defined as routine imaging at scheduled intervals, vs. clinical (C) defined as imaging triggered by either change in clinical status or change in CA19-9. Follow-up was obtained through the hospital and Cancer Data Registry records. Survival was calculated from the date of surgery to death or last follow-up, with data censored as of March 13, 2013. Kaplan–Meier survival curves were compared using the log-rank test, and Cox regression models were used for multivariate analysis.

Results

Patients were followed for a mean period of 24.35 ± 2.56 months. IS-group underwent significantly more imaging (4.41 vs. 2.08 scans/year). The most frequent imaging was CT of chest and abdomen at 3–4 month interval. Univariate associations with overall survival were detected with post-Whipple ECOG status, T-stage, N-stage, tumor grade, surgical margin, recurrence, and IS. In multivariate analysis, grade, ECOG status, and recurrence were independent predictors of survival. Also, our predictor of interest, IS, was highly associated with longer survival in multivariate modeling (median overall survival, 30.4±3.85 (IS-group) vs. 17.1 ± 2.42 (C-groups) month, log-rank p = 0.002).

Conclusion

Routine imaging surveillance was associated with prolonged overall survival post-Whipple in a multivariate model. This is a hypothesis-generating finding that should be studied prospectively and could ultimately impact surveillance guidelines.
Literatur
2.
Zurück zum Zitat Ferrone CR, Brennan MF, Gonen M, et al. (2008) Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg Off J Soc Surg Aliment Tract 12:701–706CrossRef Ferrone CR, Brennan MF, Gonen M, et al. (2008) Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg Off J Soc Surg Aliment Tract 12:701–706CrossRef
3.
Zurück zum Zitat Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300CrossRefPubMed Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300CrossRefPubMed
4.
Zurück zum Zitat Hoem D, Viste A (2012) Improving survival following surgery for pancreatic ductal adenocarcinoma–a ten-year experience. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 38:245–251 Hoem D, Viste A (2012) Improving survival following surgery for pancreatic ductal adenocarcinoma–a ten-year experience. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 38:245–251
5.
Zurück zum Zitat Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, et al. (2012) Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery 152:S43–S49CrossRefPubMedPubMedCentral Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, et al. (2012) Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Surgery 152:S43–S49CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Sener SF, Fremgen A, Menck HR, Winchester DP (1999) Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 189:1–7CrossRefPubMed Sener SF, Fremgen A, Menck HR, Winchester DP (1999) Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 189:1–7CrossRefPubMed
7.
Zurück zum Zitat Oettle H, Post S, Neuhaus P, et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277CrossRefPubMed Oettle H, Post S, Neuhaus P, et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277CrossRefPubMed
8.
Zurück zum Zitat Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85CrossRefPubMedPubMedCentral Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Riediger H, Keck T, Wellner U, et al. (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 13:1337–1344CrossRef Riediger H, Keck T, Wellner U, et al. (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 13:1337–1344CrossRef
10.
Zurück zum Zitat Van den Broeck A, Sergeant G, Ectors N, et al. (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 35:600–604 Van den Broeck A, Sergeant G, Ectors N, et al. (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 35:600–604
12.
Zurück zum Zitat Witkowski ER, Smith JK, Ragulin-Coyne E, et al. (2012) Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study. J Gastrointest Surg Off J Soc Surg Aliment Tract 16:121–128CrossRef Witkowski ER, Smith JK, Ragulin-Coyne E, et al. (2012) Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study. J Gastrointest Surg Off J Soc Surg Aliment Tract 16:121–128CrossRef
13.
Zurück zum Zitat Sheffield KM, Crowell KT, Lin Y-L, et al. (2012) Surveillance of pancreatic cancer patients after surgical resection. Ann Surg Oncol 19:1670–1677CrossRefPubMed Sheffield KM, Crowell KT, Lin Y-L, et al. (2012) Surveillance of pancreatic cancer patients after surgical resection. Ann Surg Oncol 19:1670–1677CrossRefPubMed
14.
Zurück zum Zitat Castellanos JA, Merchant NB (2014) Intensity of follow-up after pancreatic cancer resection. Ann Surg Oncol 21:747–751CrossRefPubMed Castellanos JA, Merchant NB (2014) Intensity of follow-up after pancreatic cancer resection. Ann Surg Oncol 21:747–751CrossRefPubMed
15.
Zurück zum Zitat Nordby T, Hugenschmidt H, Fagerland MW, et al. (2013) Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 39:559–566 Nordby T, Hugenschmidt H, Fagerland MW, et al. (2013) Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 39:559–566
16.
Zurück zum Zitat Heye T, Zausig N, Klauss M, et al. (2011) CT diagnosis of recurrence after pancreatic cancer: is there a pattern? World J Gastroenterol 17:1126–1134CrossRefPubMedPubMedCentral Heye T, Zausig N, Klauss M, et al. (2011) CT diagnosis of recurrence after pancreatic cancer: is there a pattern? World J Gastroenterol 17:1126–1134CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet Lond Engl 378:607–620CrossRef Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet Lond Engl 378:607–620CrossRef
18.
Zurück zum Zitat Liao W-C, Chien K-L, Lin Y-L, et al. (2013) Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. Lancet Oncol 14:1095–1103CrossRefPubMed Liao W-C, Chien K-L, Lin Y-L, et al. (2013) Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. Lancet Oncol 14:1095–1103CrossRefPubMed
19.
Zurück zum Zitat Han S-S, Jang J-Y, Kim S-W, et al. (2006) Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas 32:271–275CrossRefPubMed Han S-S, Jang J-Y, Kim S-W, et al. (2006) Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas 32:271–275CrossRefPubMed
20.
Zurück zum Zitat Rau BM, Moritz K, Schuschan S, et al. (2012) R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery 152:S103–S111CrossRefPubMed Rau BM, Moritz K, Schuschan S, et al. (2012) R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery 152:S103–S111CrossRefPubMed
21.
Zurück zum Zitat Konstantinidis IT, Warshaw AL, Allen JN, et al. (2013) Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection? Ann Surg 257:731–736CrossRefPubMed Konstantinidis IT, Warshaw AL, Allen JN, et al. (2013) Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection? Ann Surg 257:731–736CrossRefPubMed
22.
Zurück zum Zitat Laurence JM, Tran PD, Morarji K, et al. (2011) A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 15:2059–2069CrossRef Laurence JM, Tran PD, Morarji K, et al. (2011) A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract 15:2059–2069CrossRef
23.
Zurück zum Zitat Colbert LE, Hall WA, Nickleach D, et al. (2014) Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Cancer 120:499–506CrossRefPubMedPubMedCentral Colbert LE, Hall WA, Nickleach D, et al. (2014) Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Cancer 120:499–506CrossRefPubMedPubMedCentral
Metadaten
Titel
Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis
verfasst von
Azadeh Elmi
Janet Murphy
Sandeep Hedgire
Shaunagh McDermott
Seyed-Mahdi Abtahi
Elkan Halpern
Carlos Fernandez-del Castillo
Mukesh Harisinghani
Publikationsdatum
14.03.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 8/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1099-2

Weitere Artikel der Ausgabe 8/2017

Abdominal Radiology 8/2017 Zur Ausgabe

Classics in Abdominal Imaging

Snowstorm testes

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.